CCM
BEAT

Cupps Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Cupps Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-52,343
Closed -$518K – 199
2013
Q3 		$518K Buy
+52,343
New +$412K 0.03% 127

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cupps Capital Management's BEAT Position: Q4 2013 in Review

Cupps Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2013, closing a stake of 52,343 shares — an estimated $518K sold.

Cupps Capital Management first reported a position in BEAT in Q3 2013 and held it in 1 quarter. The position peaked at $518K in Q3 2013. 77 funds tracked by Wall St. Rank hold BEAT as of Q4 2013.

  • Cupps Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2013 after selling out during the quarter.
  • Cupps Capital Management sold 52,343 BioTelemetry, Inc. shares in Q4 2013, an estimated $518K.
  • Cupps Capital Management first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 1 quarter.
  • Cupps Capital Management's BioTelemetry, Inc. position peaked at $518K in Q3 2013.
  • 77 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2013.

Based on Cupps Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.